Dai Ke-sheng, Zhu Huai-ping, Jiang Miao, Ruan Chang-geng
The First Affiliated Hospital of Suzhou University, Jiangsu Institute of Hematology, Suzhou 215006, China.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2003 Jan;19(1):71-3, 79.
To reduce immunogenicity of a monoclonal antibody SZ-2 specific for human platelet.
Reverse transcription and polymerize chain reaction were used to amplify the variable region genes of monoclonal antibody SZ-2. The cloned V(H) and V(L) genes were sequenced and fused to human IgG1 constant region gene CH1 and Ckappa in plasmid pSW1. The recombinant plasmid were transformed into E. coli. The expressed recombinant proteins were analysed.
The V(H) and V(L) genes were homologous with the published gene sequences of mouse antibody variable region. The concentration of chimeric Fab fragment in expression supernatant was about 180 microg/L detected by ELISA. Western blot analysis showed that SZ-2 Fab/Hu maintained the binding activity to human platelet GPIb. The recombinant proteins could suppress platelet aggregation induced by Ristocatin.
The variable region genes of SZ-2 are cloned and the mouse-human chimeric Fab fragment is expressed successfully in E. coli.
降低针对人血小板的单克隆抗体SZ-2的免疫原性。
采用逆转录聚合酶链反应扩增单克隆抗体SZ-2的可变区基因。对克隆的V(H)和V(L)基因进行测序,并在质粒pSW1中与人IgG1恒定区基因CH1和Cκ融合。将重组质粒转化到大肠杆菌中。对表达的重组蛋白进行分析。
V(H)和V(L)基因与已发表的小鼠抗体可变区基因序列同源。通过ELISA检测,表达上清中嵌合Fab片段的浓度约为180μg/L。蛋白质印迹分析表明,SZ-2 Fab/Hu保持了与人血小板糖蛋白Ib的结合活性。重组蛋白可抑制瑞斯托菌素诱导的血小板聚集。
克隆了SZ-2的可变区基因,并在大肠杆菌中成功表达了鼠-人嵌合Fab片段。